Medinice S.A.

Regulatory Filings • Mar 20, 2023

The Management Board of Medinice S.A. (Issuer, Company) announces thattoday, has entered into an agreement with Clairfield Partners LLC, NewYork ( Advisor , Clairfield ), to advise on the commercialisationprocess of medical devices under development by the Company. Clairfieldwill play an advisory role in, among other things, the due diligenceprocess and negotiation strategy. The advisor will also act ascoordinator of the processes required by the transaction partners. Thecooperation will cover key projects carried out by the Issuer, i.e.Pacepress_#174; [smart dressing], CoolCryo_#174; [cryoablation system], Minimax_#174;[RF ablation electrode with 3D mapping], EpBioptom_#174; [biopsy electrodewith 3D mapping]and AtriClamp_#174; [clamp for LAAO], you can read more aboutthe products on the Issuer's website.

The remuneration for the services comprises a fixed part and a variablepart in the form of a success fee. The terms and conditions of theagreement do not differ from those commonly used for such agreements inthis sector. The Issuer's Management Board considered this informationimportant due to the fact that the performance of the subject of theagreement will have a significant impact on the Company's operations andfinancial position.

Clairfield Partners LLC is part of Clairfield International SA, aninternational company providing corporate advisory services, mainly inthe field of mergers and acquisitions, to multinational corporations andfinancial investors. Clairfield has extensive experience in, among otherthings, mergers and acquisitions in the areas of medical technology andbiotechnology.